HealthEquity Inc. (NASDAQ:HQY) insider Jon Kessler sold 20,000 shares of HealthEquity stock in a transaction dated Thursday, September 15th. The stock was sold at an average price of $33.46, for a total value of $669,200.00. Following the completion of the sale, the insider now owns 440,000 shares in the company, valued at $14,722,400. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Jon Kessler also recently made the following trade(s):

  • On Monday, September 12th, Jon Kessler sold 120,117 shares of HealthEquity stock. The stock was sold at an average price of $33.10, for a total value of $3,975,872.70.
  • On Wednesday, August 31st, Jon Kessler sold 34,883 shares of HealthEquity stock. The stock was sold at an average price of $33.00, for a total value of $1,151,139.00.
  • On Monday, July 25th, Jon Kessler sold 10,000 shares of HealthEquity stock. The stock was sold at an average price of $29.62, for a total value of $296,200.00.
  • On Friday, July 15th, Jon Kessler sold 10,000 shares of HealthEquity stock. The stock was sold at an average price of $30.05, for a total value of $300,500.00.
  • On Thursday, June 23rd, Jon Kessler sold 10,000 shares of HealthEquity stock. The stock was sold at an average price of $29.00, for a total value of $290,000.00.

Shares of HealthEquity Inc. (NASDAQ:HQY) opened at 35.45 on Wednesday. The stock has a market cap of $2.08 billion, a price-to-earnings ratio of 90.90 and a beta of 1.65. HealthEquity Inc. has a 52-week low of $15.80 and a 52-week high of $35.78. The stock’s 50 day moving average is $31.34 and its 200 day moving average is $27.70.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, September 6th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.03. The firm earned $44.20 million during the quarter. HealthEquity had a net margin of 15.21% and a return on equity of 10.89%. The company’s revenue for the quarter was up 44.9% on a year-over-year basis. During the same period in the prior year, the company earned $0.08 earnings per share. On average, equities analysts expect that HealthEquity Inc. will post $0.51 earnings per share for the current fiscal year.

Hedge funds and other institutional investors have recently modified their holdings of the stock. BlackRock Inc. boosted its position in shares of HealthEquity by 56.5% in the second quarter. BlackRock Inc. now owns 3,594 shares of the company’s stock worth $109,000 after buying an additional 1,297 shares during the period. PineBridge Investments L.P. boosted its position in shares of HealthEquity by 4.3% in the second quarter. PineBridge Investments L.P. now owns 4,482 shares of the company’s stock worth $137,000 after buying an additional 186 shares during the period. Teacher Retirement System of Texas boosted its position in shares of HealthEquity by 43.9% in the second quarter. Teacher Retirement System of Texas now owns 6,061 shares of the company’s stock worth $184,000 after buying an additional 1,850 shares during the period. Denver Investment Advisors LLC bought a new position in shares of HealthEquity during the second quarter worth about $203,000. Finally, Mason Street Advisors LLC bought a new position in shares of HealthEquity during the second quarter worth about $210,000. 91.41% of the stock is owned by institutional investors.

Several equities research analysts recently issued reports on the company. Zacks Investment Research upgraded HealthEquity from a “hold” rating to a “buy” rating and set a $39.00 price objective on the stock in a report on Thursday, September 8th. SunTrust Banks Inc. restated a “buy” rating on shares of HealthEquity in a report on Thursday, September 8th. Barrington Research boosted their target price on HealthEquity from $34.00 to $38.00 and gave the stock an “outperform” rating in a report on Thursday, September 8th. Robert W. Baird boosted their target price on HealthEquity from $31.00 to $35.00 and gave the stock a “neutral” rating in a report on Wednesday, September 7th. Finally, Raymond James Financial Inc. boosted their target price on HealthEquity from $32.00 to $40.00 and gave the stock an “outperform” rating in a report on Monday, September 12th. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $36.00.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

5 Day Chart for NASDAQ:HQY

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.